腹膜炎は、胃の粘膜の炎症または腫れを特徴とします。急性腹膜炎は短期間、慢性腹膜炎は長期間（数ヶ月から数年）続きます。腹膜炎は、イブプロフェン、アスピリン、ナプロキセンなどの薬の長期服用、アルコールの過剰摂取、ヘリコバクターピロリ感染、特定の自己免疫疾患、胆汁逆流、薬物乱用（コカイン）、毒物などの腐食・腐蝕物質の摂取、強いストレス、ウイルス感染、外傷などによって引き起こされることがあります。腹膜炎の症状には、食欲不振、吐き気、嘔吐、腹痛、黒色便などがあります。治療には、制酸薬、ヒスタミン2（H2）拮抗薬、プロトンポンプ阻害薬などが使用されます。
目次
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Peritonitis - Overview
Peritonitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Peritonitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Peritonitis - Companies Involved in Therapeutics Development
Peritonitis - Drug Profiles
Peritonitis - Dormant Projects
Peritonitis - Product Development Milestones
Featured News & Press Releases
Apr 26, 2021: Cantargia presents new preclinical data on antibody CAN10 at IMMMUNOLOGY2021
Jun 19, 2016: Reponex Pharmaceuticals: The Danish Medicines Agency has approved the clinical trial protocol for the peritonitis project
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Peritonitis, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Peritonitis - Pipeline by Arrevus Inc, 2022
Peritonitis - Pipeline by Ayuvis Research Inc, 2022
Peritonitis - Pipeline by Cantargia AB, 2022
Peritonitis - Pipeline by Hunan Sanqing Pharmaceutical Co Ltd, 2022
Peritonitis - Pipeline by InflaRx NV, 2022
Peritonitis - Pipeline by Jiangsu Sinoyoung Bio-Pharmaceutical Co Ltd, 2022
Peritonitis - Pipeline by Nosopharm SAS, 2022
Peritonitis - Pipeline by Oncodesign SA, 2022
Peritonitis - Pipeline by Pfizer Inc, 2022
Peritonitis - Pipeline by Reponex Pharmaceuticals AS, 2022
Peritonitis - Pipeline by SynAct Pharma AB, 2022
Peritonitis - Dormant Projects, 2022
List of Figures
Number of Products under Development for Peritonitis, 2022
Number of Products under Development by Companies, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022
